Latest Form 4 insider transactions

Alexander J Pourbaix, a Director of Nrg Energy, Inc., received 44 shares of common stock on August 3, 2026.

Mark Reddout, President of North America of Innovex International, Inc., sold 10,000 shares of common stock on August 4, 2026 for $30.00 per share.

Sanjay Kapoor, a Director of Nrg Energy, Inc., received 13 shares of common stock on August 3, 2026.

Alexandra Pruner, a Director of Nrg Energy, Inc., received 112 shares of common stock on August 3, 2026.

John Tull Meyer, EVP of Terreno Realty Corp, reported multiple transactions in common stock on August 3, 2026.

Michael F Steib, a Director of Angi Inc., received 40,257 shares of common stock on August 4, 2026.

Mark B. Rourke, Executive Chair and a Director of Schneider National, Inc., sold 72,994 shares of common stock on August 3, 2026.

Marcie Zlotnik, a Director of Nrg Energy, Inc., received 29 shares of common stock on August 3, 2026.

Jeffrey D. Shellberg, a Director of Bridgewater Bancshares Inc, sold 160,000 shares of common stock on August 5, 2026 for $21.04 per share.

Charles Kane, a Director of Symbotic Inc., sold 2,000 shares of common stock on August 3, 2026 for $43.21 per share.

Todd Krasnow, a Director of Symbotic Inc., sold 2,000 shares of common stock on August 3, 2026.

Izilda P Martins, Chief Financial Officer of Symbotic Inc., sold 27,463 shares of common stock on July 23, 2026 for $40.80 per share.

John Mcclain Holmes Iii, a Director of Gatx Corp, received 142 shares of common stock on August 3, 2026.

Daniel J Castillo, EVP & GM, EES of Wesco International Inc, purchased 960 shares of common stock on August 4, 2026 for $365.89 per share.

David C Harvey, EVP Chief Operating Officer of Cvb Financial Corp, sold 40,000 shares of common stock on August 5, 2026 for $22.94 per share.

Sean Maduck, See Remarks of Corcept Therapeutics Inc, sold 20,305 shares of common stock on August 3, 2026 for $114.70 per share.

Marc Prieur, Segment President of Aptargroup, Inc., sold 3,500 shares of common stock on August 4, 2026.

Joseph Douglas Lyon, See Remarks of Corcept Therapeutics Inc, sold 1,540 shares of common stock on August 3, 2026 for $114.16 per share.

Mark & Robyn Jones Descendants Trust 2014 and 2 others reported changes in beneficial ownership of Goosehead Insurance, Inc. common stock on August 3, 2026.

Jeffrey S Lyon, a Director of Heritage Financial Corp /Wa/, sold 10,000 shares of common stock on August 5, 2026 for $30.00 per share.

Tony Chalfant, EVP Chief Credit Officer of Heritage Financial Corp /Wa/, sold 3,234 shares of common stock on August 5, 2026 for $29.92 per share.

Shelley J Bausch, a Director of Gatx Corp, received 142 shares of common stock on August 3, 2026.

Mary Jayne Crocker, a Director of Bridgewater Bancshares Inc, sold 11,000 shares of common stock on August 4, 2026 for $21.04 per share.

5AM Partners VI, LLC and 6 others reported changes in beneficial ownership of Camp4 Therapeutics Corp common stock on August 3, 2026.

W Carl Kester, a Director of BlackRock Enhanced Equity Dividend Trust, received 7 shares of common stock on August 3, 2026.

W Carl Kester, a Director of Blackrock Enhanced Capital & Income Fund, Inc., received 3 shares of common stock on August 3, 2026.

Arthur Philip Steinmetz, a Director of BlackRock Enhanced Equity Dividend Trust, received 29 shares of common stock on August 3, 2026.

Arthur Philip Steinmetz, a Director of Blackrock Credit Allocation Income Trust, received 50 shares of common stock on August 3, 2026.

Gregory Baszucki, a Director of Roblox Corp, sold 16,666 shares of common stock on August 4, 2026.

Jude Onyia, Chief Scientific Officer of Neurocrine Biosciences Inc, reported a transaction in 2,409 shares of common stock on August 4, 2026.